Individuals with multiple sclerosis develop progressive neurological disability that is thought to be caused by degradation of nerve cells.

A new study has characterized an agent that protected nerve cells from damage in culture and markedly reduced disease progression in a mouse model of MS.

The authors of the study therefore suggested that agents similar to the one they characterized might provide a new approach to treating individuals with MS and other neurodegenerative disorders.

...